Advanced Drug Delivery Systems Global Market Opportunities And Strategies To 2033
상품코드:1470349
리서치사:The Business Research Company
발행일:2024년 04월
페이지 정보:영문 358 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
전 세계 첨단 약물전달 시스템 시장 규모는 2018년 1,922억 1,420만 달러로 2023년까지 복합 연간 성장률(CAGR) 6.0% 이상으로 성장했습니다.
원격 의료 서비스 이용 확대
원격 의료 서비스의 이용 확대는 과거 기간에 첨단 약물전달 시스템 시장의 성장을 지원했습니다. 원격 의료는 통신 장비 및 디지털 플랫폼과 같은 기술을 이용하여 원격지에서 환자에게 의료 조언, 평가, 치료 및 후속 조치를 제공하는 건강 관리의 일종입니다. 약물전달 시스템을 원격 의료에 통합하면 간편하고 효율적인 건강 관리를 제공할 수 있으며, 환자가 의료 종사자와 시설에서 지리적으로 떨어져 있더라도 적절한 약물, 지원 및 조언을 제공합니다. 받을 수 있게 됩니다. 디지털 처방, 의료 소개 네트워크, 마이 헬스 레코드를 담당하는 호주 정부 기관 Australian Digital Health Agency에 따르면, 2020년 3월-2022년 7월 사이에 1억 1,820만명의 원격 의료 치료 서비스가 1,800만명 에 제공되며 95,000 명 이상의 개업 의사가 원격 의료 서비스를 이용합니다. 따라서 원격의료서비스 이용 확대는 첨단 약물 전달시스템 시장의 성장을 뒷받침했습니다.
목차
제1장 주요 요약
고급 약물전달 시스템 - 시장의 매력과 거시 경제 상황
제2장 목차
제3장 표제 목록
제4장 도표 일람
제5장 보고서 구성
제6장 시장 특징
일반적인 시장의 정의
개요
고급 약물전달 시스템 시장 정의와 세분화
시장 세분화 : 유형별
경구 약물 전달 시스템
주사식 약물전달 시스템
흡입/폐 약물 전달 시스템
경피 약물 전달 시스템
경점막 약물 전달 시스템
캐리어 기반 약물전달 시스템
기타 유형
시장 세분화:캐리어 유형별
리포솜
나노입자
마이크로 스피어
단클론항체
기타 캐리어 유형
시장 세분화 : 기술별
프로드러그
임플란트와 자궁내 피임기구
타겟 약물전달
폴리머 약물전달
기타 기술
시장 세분화:용도별
종양학
항감염
중추신경계
호흡기 질환
심혈관 질환
근골격 장애
대사 장애
기타 용도
시장 세분화 : 최종 사용자별
병원
전문 클리닉
기타 최종 사용자
제7장 주요 시장 동향
고급 약물전달 기술에 의한 전임상 의약품 개발의 도입
용해성 마이크로니들에 의한 약물전달 방법의 초점 강화
피하 치료를 위한 혁신적인 체내 투여 시스템
박막 제제에 의한 선진 약물전달의 개발
시장에서의 혁신과 확대를 추진하기 위한 시장기업간의 전략적 파트너십과 콜라보레이션
제8장 첨단 약물전달 시스템 시장 : 거시경제 시나리오
COVID-19가 첨단 약물전달 시스템 시장에 미치는 영향
우크라이나 전쟁이 첨단 약물전달 시스템 시장에 미치는 영향
고인플레이션이 고급 약물전달 시스템 시장에 미치는 영향
제9장 시장 규모와 성장
시장 규모
시장 성장 실적(2018년-2023년)
시장 성장 촉진요인(2018년-2023년)
시장 성장 억제요인(2018년-2023년)
시장 성장 예측(2023년-2028년, 2033년)
시장 성장 촉진요인(2023년-2028년)
시장 성장 억제요인(2023년-2028년)
제10장 세계 첨단 약물전달 시스템 시장 세분화
세계 첨단 약물전달 시스템 시장 : 유형별, 실적과 예측(2018년-2023년, 2028년, 2033년)
세계 첨단 약물전달 시스템 시장 : 용도별, 실적과 예측(2018년-2023년, 2028년, 2033년)
세계 첨단 약물전달 시스템 시장 : 최종 사용자별, 실적과 예측(2018년-2023년, 2028년, 2033년)
세계 첨단 약물전달 시스템 시장 :캐리어 유형별, 실적과 예측(2018년-2023년, 2028년, 2033년)
세계 첨단 약물전달 시스템 시장 :기술별, 실적과 예측(2018년-2023년, 2028년, 2033년)
제11장 고급 약물전달 시스템 시장 : 지역 및 국가별 분석
세계 첨단 약물전달 시스템 시장 :지역별, 실적과 예측(2018년-2023년, 2028년, 2033년)
세계 첨단 약물전달 시스템 시장 : 국가별, 실적과 예측(2018년-2023년, 2028년, 2033년)
제12장 아시아태평양 시장
제13장 서유럽 시장
제14장 동유럽 시장
제15장 북미 시장
제16장 남미 시장
제17장 중동 시장
제18장 아프리카 시장
제19장 경쟁 구도와 기업 프로파일
기업 프로파일
Johnson & Johnson
기업 개요
제품 및 서비스
비즈니스 전략
재무 개요
Baxter
기업 개요
제품 및 서비스
비즈니스 전략
재무 개요
Becton, Dickinson and Company
기업 개요
제품 및 서비스
비즈니스 전략
재무 개요
Medtronic Plc
기업 개요
제품 및 서비스
비즈니스 전략
재무 개요
Pacira BioSciences, Inc.
기업 개요
제품 및 서비스
재무 개요
제20장 기타 주요 기업 및 혁신 기업
Abbvie, Inc.
기업 개요
제품 및 서비스
비즈니스 전략
Gilead Sciences, Inc.
기업 개요
제품 및 서비스
비즈니스 전략
Merck KGaA
기업 개요
제품 및 서비스
비즈니스 전략
Danaher Corporation
기업 개요
제품 및 서비스
Bausch Health Companies Inc
기업 개요
제품 및 서비스
비즈니스 전략
Evonik Industries AG
기업 개요
제품 및 서비스
비즈니스 전략
Ypsomed Holding AG
기업 개요
제품 및 서비스
비즈니스 전략
SHL Medical AG
기업 개요
제품 및 서비스
비즈니스 전략
West Pharmaceutical Services, Inc
기업 개요
제품 및 서비스
비즈니스 전략
Novo Nordisk A/S
기업 개요
제품 및 서비스
비즈니스 전략
Purdue Pharma LP
기업 개요
제품 및 서비스
Luye Pharma Group Ltd.
기업 개요
제품 및 서비스
Ipsen Biopharmaceuticals, Inc
기업 개요
제품 및 서비스
비즈니스 전략
Sun Pharmaceutical Inc
기업 개요
제품 및 서비스
비즈니스 전략
Takeda Pharmaceutical Company Limited
기업 개요
제품 및 서비스
제21장 경쟁 벤치마킹
제22장 경쟁 대시보드
제23장 주요 인수합병(M&A)
Cordis Corporation Acquired MedAlliance SA
DifGen Pharmaceuticals Acquired Aveva Drug Delivery Services Inc
LTS Lohmann Therapie-Systeme Acquired Sorrel Wearable Injection Device Business From Eitan Medical
Advanced drug delivery systems (ADDS) refer to innovative and sophisticated techniques or technologies designed to enhance the delivery of therapeutic agents (drugs) to specific target sites in the body. ADDS encompass a broad range of approaches, including formulations, carriers and strategies that aim to improve the efficacy, safety and patient compliance of drug delivery.
The advanced drug delivery systems market consists of sales, by entities (organizations, partnerships and sole proprietors), of advanced drug delivery systems that include technologies and methodologies to deliver drugs to specific parts of the body in a controlled manner.
The global advanced drug delivery systems market was valued at $192,214.2 million in 2018 which grew till 2023 at a compound annual growth rate (CAGR) of more than 6.0%.
Growing Use Of Telemedicine Services
The growing use of telemedicine services supported the growth of the advanced drug delivery systems market during the historic period. Telemedicine is a type of healthcare that involves the use of technology, namely telecommunication equipment and digital platforms, to provide healthcare advice, evaluation, therapy and follow-up to patients remotely. Incorporating drug delivery systems with telemedicine facilitates simple and efficient healthcare delivery, assuring patients receive appropriate drugs, support and advice, even if they are geographically separated from healthcare practitioners or facilities. According to the Australian Digital Health Agency, an Australia-based government organization in charge of digital prescriptions, medical referral networks and My Health Record, 118.2 million telehealth therapy services were offered to 18 million people between March 2020 and July 2022, and more than 95,000 practitioners employ telehealth services. Therefore, the growing use of telemedicine services supported the growth of the advanced drug delivery systems market.
Introducing Preclinical Drug Development With Advanced Drug Delivery Technology
Companies are introducing preclinical drug development with advanced drug delivery technology (EUDRACAP) to accelerate innovation, unlock value and improve quality in the preclinical development stage. This is used to enhance preclinical drug development by offering functional, ready-to-fill oral capsules. These capsules simplify the drug development process, reduce time and variables and safeguard the active ingredient to optimize absorption rates and prevent premature degradation. For example, in October 2023, Evonik, a German-based specialty chemicals company, launched an advanced drug delivery system, called EUDRACAP preclinic enteric, a functional oral capsule designed for use in preclinical trials. This capsule is a very small, 9-h (5.1 mm) technical-grade capsule, suitable for passing through the gastrointestinal tract of preclinical subjects. The capsule simplifies drug development by reducing time, cost and variables and leverages EUDRAGIT(R) functional coatings for optimized release profiles, while offering custom options for specific active pharmaceutical ingredient (API), formulation and brand requirements and a seamless transition from preclinical to clinical and commercial stages, with support for custom capsule coatings, formulation development and current good manufacturing practice (cGMP) scale-up.
The global advanced drug delivery systems market is highly fragmented, with a large number of players operating in the market. The top ten competitors in the market made up to 2.91% of the total market in 2022.
Advanced Drug Delivery Systems Global Market Opportunities And Strategies To 2033 from The Business Research Company provides the strategists; marketers and senior management with the critical information they need to assess the global advanced drug delivery systems market as it emerges from the COVID-19 shut down.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
Create regional and country strategies based on local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market research findings.
Benchmark performance against key competitors.
Utilize the relationships between key data sets for superior strategizing.
Suitable for supporting your internal and external presentations with reliable high-quality data and analysis.
Where is the largest and fastest-growing market for advanced drug delivery systems? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The advanced drug delivery systems market global report from The Business Research Company answers all these questions and many more.
The report covers market characteristics; size and growth; segmentation; regional and country breakdowns; competitive landscape; market shares; trends and strategies for this market. It traces the market's history and forecasts market growth by geography. It places the market within the context of the wider advanced drug delivery systems market; and compares it with other markets.
The report covers the following chapters:
Introduction And Market Characteristics- Brief introduction to the segmentations covered in the market, definitions and explanations about the segment by type, by carrier type, by technology, by application and by end user.
Key Trends- Highlights the major trends shaping the global market. This section also highlights likely future developments in the market.
Macro-Economic Scenario- The report provides an analysis of the impact of the COVID-19 pandemic, impact of the Russia-Ukraine war and impact of rising inflation on global and regional markets, providing strategic insights for businesses in the advanced drug delivery systems market.
Global Market Size And Growth- Global historic (2018-2023) and forecast (2023-2028, 2033F) market values and drivers and restraints that support and control the growth of the market in the historic and forecast periods.
Regional And Country Analysis- Historic (2018-2023) and forecast (2023-2028, 2033F) market values and growth and market share comparison by region and country.
Market Segmentation- Contains the market values (2018-2023) (2023-2028, 2033F) and analysis for each segment by type, by carrier type, by technology, by application and by end user in the market. Historic (2018-2023) and forecast (2023-2028) and (2028-2033) market values and growth and market share comparison by region market.
Regional Market Size And Growth - Regional market size (2023), historic (2018-2023) and forecast (2023-2028, 2033F) market values and growth and market share comparison of countries within the region. This report includes information on all the regions Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa and major countries within each region.
Competitive Landscape- Details on the competitive landscape of the market, estimated market shares and company profiles of the leading players.
Other Major And Innovative Companies- Details on the company profiles of other major and innovative companies.
Competitive Benchmarking- Briefs on the financials comparison between major players in the market
Competitive Dashboard- Briefs on competitive dashboard of major players.
Key Mergers And Acquisitions- Information on recent mergers and acquisitions in the market covered in the report. This section gives key financial details of mergers and acquisitions, which have shaped the market in recent years.
Market Opportunities And Strategies - Describes market opportunities and strategies based on findings of the research, with information on growth opportunities across countries, segments and strategies to be followed in those markets.
Conclusions And Recommendations - This section includes recommendations for advanced drug delivery systems providers in terms of product/service offerings geographic expansion, marketing strategies and target groups.
Appendix - This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.
Scope
Markets Covered:
1) By Type: Oral Drug Delivery System; Injection-Based Drug Delivery System; Inhalation/Pulmonary Drug Delivery System; Transdermal Drug Delivery System; Transmucosal Drug Delivery System; Carrier-Based Drug Delivery System And Other Types
2) By Carrier Type: Liposomes; Nanoparticles; Microspheres; Monoclonal Antibodies; Other Carrier Types
3) By Technology: Prodrug; Implants And Intrauterine Devices; Targeted Drug Delivery; Polymeric Drug Delivery; Other Technologies
4) By Application: Oncology; Anti-Infective; Central Nervous System; Respiratory Diseases; Cardiovascular Diseases; Musculoskeletal Disorders; Metabolic Disorders; Other Applications
5) 4) By End User: Hospitals; Specialized Clinics; Other End Users
Companies Mentioned: Johnson & Johnson, Inc; Baxter; Becton, Dickinson And Company; Medtronic Plc; Pacira Biosciences, Inc
Countries: China; Australia; India; Indonesia; Japan; South Korea; USA; Canada; Brazil; France; Germany; UK; Italy; Spain; Russia
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time-series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets; GDP proportions; expenditure per capita; advanced drug delivery systems indicators comparison.
Data segmentations: country and regional historic and forecast data; market share of competitors; market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Table of Contents
1 Executive Summary
1.1 Advanced Drug Delivery Systems - Market Attractiveness And Macro economic Landscape
2 Table Of Contents
3 List Of Tables
4 List Of Figures
5 Report Structure
6 Market Characteristics
6.1 General Market Definition
6.2 Summary
6.3 Advanced Drug Delivery Systems Market Definition And Segmentations
6.4 Market Segmentation By Type
6.4.1 Oral Drug Delivery System
6.4.2 Injection-Based Drug Delivery System
6.4.3 Inhalation/Pulmonary Drug Delivery System
6.4.4 Transdermal Drug Delivery System
6.4.5 Transmucosal Drug Delivery System
6.4.6 Carrier-Based Drug Delivery System
6.4.7 Other Types
6.5 Market Segmentation By Carrier Type
6.5.1 Liposomes
6.5.2 Nanoparticles
6.5.3 Microspheres
6.5.4 Monoclonal Antibodies
6.5.5 Other Carrier Types
6.6 Market Segmentation By Technology
6.6.1 Prodrug
6.6.2 Implants And Intrauterine Devices
6.6.3 Targeted Drug Delivery
6.6.4 Polymeric Drug Delivery
6.6.5 Other Technologies
6.7 Market Segmentation By Application
6.7.1 Oncology
6.7.2 Anti-Infective
6.7.3 Central Nervous System
6.7.4 Respiratory Diseases
6.7.5 Cardiovascular Diseases
6.7.6 Musculoskeletal Disorders
6.7.7 Metabolic Disorders
6.7.8 Other Application
6.8 Market Segmentation By End User
6.8.1 Hospitals
6.8.2 Specialized Clinics
6.8.3 Other End Users
7 Major Market Trends
7.1 Introducing Preclinical Drug Development With Advanced Drug Delivery Technology
7.2 Increasing Focus Dissolving Microneedle Drug Delivery Methods
7.3 Innovative On-Body Delivery Systems For Subcutaneous Therapies
7.4 Pioneering Advanced Drug Delivery With Thin Film Formulation
7.5 Strategic Partnerships And collaborations Among Market Players To Drive Innovation and Expansion In The Market
8 Advanced Drug Delivery Systems Market - Macro Economic Scenario
8.1 COVID-19 Impact On The Advanced Drug Delivery Systems Market
8.2 Impact Of The War In Ukraine On The Advanced Drug Delivery Systems Market
8.3 Impact Of High Inflation On The Advanced Drug Delivery Systems Market
9 Global Market Size and Growth
9.1 Market Size
9.2 Historic Market Growth, 2018 - 2023, Value ($ Million)
10 Global Advanced Drug Delivery Systems Market Segmentation
10.1 Global Advanced Drug Delivery Systems Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
10.2 Global Advanced Drug Delivery Systems Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
10.3 Global Advanced Drug Delivery Systems Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
10.4 Global Advanced Drug Delivery Systems Market, Segmentation By Carrier Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
10.5 Global Advanced Drug Delivery Systems Market, Segmentation By Technology, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
11 Advanced Drug Delivery Systems Market, Regional and Country Analysis
11.1 Global Advanced Drug Delivery Systems Market, By Region, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
11.2 Global Advanced Drug Delivery Systems Market, By Country, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12 Asia-Pacific Market
12.1 Summary
12.1.1 Market Overview
12.1.2 Region Information
12.1.3 Market Information
12.1.4 Background Information
12.1.5 Government Initiatives
12.1.6 Regulations
12.1.7 Regulatory Bodies
12.1.8 Major Associations
12.1.9 Taxes Levied
12.1.10 Corporate Tax Structure
12.1.11 Investments
12.1.12 Major Companies
12.2 Asia-Pacific Advanced Drug Delivery Systems Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.3 Asia-Pacific Advanced Drug Delivery Systems Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.4 Asia-Pacific Advanced Drug Delivery Systems Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.5 Asia-Pacific Advanced Drug Delivery Systems Market: Country Analysis
12.6 China Market
12.7 Summary
12.7.1 Market Overview
12.7.2 Country Information
12.7.3 Market Information
12.7.4 Background Information
12.7.5 Government Initiatives
12.7.6 Regulations
12.7.7 Regulatory Bodies
12.7.8 Major Associations
12.7.9 Taxes Levied
12.7.10 Corporate Tax Structure
12.7.11 Investments
12.7.12 Major Companies
12.8 China Advanced Drug Delivery Systems Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.9 China Advanced Drug Delivery Systems Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.10 China Advanced Drug Delivery Systems Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.11 India Market
12.12 India Advanced Drug Delivery Systems Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.13 India Advanced Drug Delivery Systems Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.14 India Advanced Drug Delivery Systems Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.15 Japan Market
12.16 Japan Advanced Drug Delivery Systems Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.17 Japan Advanced Drug Delivery Systems Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.18 Japan Advanced Drug Delivery Systems Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.19 Australia Market
12.20 Australia Advanced Drug Delivery Systems Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.21 Australia Advanced Drug Delivery Systems Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.22 Australia Advanced Drug Delivery Systems Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.23 Indonesia Market
12.24 Indonesia Advanced Drug Delivery Systems Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.25 Indonesia Advanced Drug Delivery Systems Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.26 Indonesia Advanced Drug Delivery Systems Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.27 South Korea Market
12.28 South Korea Advanced Drug Delivery Systems Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.29 South Korea Advanced Drug Delivery Systems Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.30 South Korea Advanced Drug Delivery Systems Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
13 Western Europe Market
13.1 Summary
13.1.1 Market Overview
13.1.2 Region Information
13.1.3 Market Information
13.1.4 Background Information
13.1.5 Government Initiatives
13.1.6 Regulations
13.1.7 Regulatory Bodies
13.1.8 Major Associations
13.1.9 Taxes Levied
13.1.10 Corporate Tax Structure
13.1.11 Investments
13.1.12 Major Companies
13.1 Western Europe Advanced Drug Delivery Systems Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
13.2 Western Europe Advanced Drug Delivery Systems Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
13.3 Western Europe Advanced Drug Delivery Systems Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
13.4 Western Europe Advanced Drug Delivery Systems Market: Country Analysis
13.5 UK Market
13.6 UK Advanced Drug Delivery Systems Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
13.7 UK Advanced Drug Delivery Systems Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
13.8 UK Advanced Drug Delivery Systems Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
13.9 Germany Market
13.10 Germany Advanced Drug Delivery Systems Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
13.11 Germany Advanced Drug Delivery Systems Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
13.12 Germany Advanced Drug Delivery Systems Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
13.13 France Market
13.14 France Advanced Drug Delivery Systems Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
13.15 France Advanced Drug Delivery Systems Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
13.16 France Advanced Drug Delivery Systems Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
13.17 Italy Market
13.18 Italy Advanced Drug Delivery Systems Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
13.19 Italy Advanced Drug Delivery Systems Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
13.20 Italy Advanced Drug Delivery Systems Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
13.21 Spain Market
13.22 Spain Advanced Drug Delivery Systems Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
13.23 Spain Advanced Drug Delivery Systems Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
13.24 Spain Advanced Drug Delivery Systems Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
14 Eastern Europe Market
14.1 Summary
14.1.1 Market Overview
14.1.2 Region Information
14.1.3 Market Information
14.1.4 Background Information
14.1.5 Government Initiatives
14.1.6 Regulations
14.1.7 Regulatory Bodies
14.1.8 Major Associations
14.1.9 Taxes Levied
14.1.10 Corporate Tax Structure
14.1.11 Investments
14.1.12 Major Companies
14.2 Eastern Europe Advanced Drug Delivery Systems Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
14.3 Eastern Europe Advanced Drug Delivery Systems Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
14.4 Eastern Europe Advanced Drug Delivery Systems Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
14.5 Eastern Europe Advanced Drug Delivery Systems Market: Country Analysis
14.6 Russia Market
14.7 Russia Advanced Drug Delivery Systems Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
14.8 Russia Advanced Drug Delivery Systems Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
14.9 Russia Advanced Drug Delivery Systems Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
15 North America Market
15.1 Summary
15.1.1 Market Overview
15.1.2 Region Information
15.1.3 Market Information
15.1.4 Background Information
15.1.5 Government Initiatives
15.1.6 Regulations
15.1.7 Regulatory Bodies
15.1.8 Major Associations
15.1.9 Taxes Levied
15.1.10 Corporate Tax Structure
15.1.11 Investments
15.1.12 Major Companies
15.2 North America Advanced Drug Delivery Systems Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
15.3 North America Advanced Drug Delivery Systems Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
15.4 North America Advanced Drug Delivery Systems Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
15.5 North America Advanced Drug Delivery Systems Market: Country Analysis
15.6 USA Market
15.7 Summary
15.7.1 Market Overview
15.7.2 Country Information
15.7.3 Market Information
15.7.4 Background Information
15.7.5 Government Initiatives
15.7.6 Regulations
15.7.7 Regulatory Bodies
15.7.8 Major Associations
15.7.9 Taxes Levied
15.7.10 Corporate Tax Structure
15.7.11 Investments
15.7.12 Major Companies
15.8 USA Advanced Drug Delivery Systems Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
15.9 USA Advanced Drug Delivery Systems Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
15.10 USA Advanced Drug Delivery Systems Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
15.11 Canada Market
15.12 Canada Advanced Drug Delivery Systems Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
15.13 Canada Advanced Drug Delivery Systems Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
15.14 Canada Advanced Drug Delivery Systems Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
16 South America Market
16.1 Summary
16.1.1 Market Overview
16.1.2 Region Information
16.1.3 Market Information
16.1.4 Background Information
16.1.5 Government Initiatives
16.1.6 Regulations
16.1.7 Regulatory Bodies
16.1.8 Major Associations
16.1.9 Taxes Levied
16.1.10 Corporate Tax Structure
16.1.11 Investments
16.1.12 Major Companies
16.2 South America Advanced Drug Delivery Systems Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
16.3 South America Advanced Drug Delivery Systems Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
16.4 South America Advanced Drug Delivery Systems Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
16.5 South America Advanced Drug Delivery Systems Market: Country Analysis
16.6 Brazil Market
16.7 Brazil Advanced Drug Delivery Systems Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
16.8 Brazil Advanced Drug Delivery Systems Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
16.9 Brazil Advanced Drug Delivery Systems Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
17 Middle East Market
17.1 Summary
17.1.1 Market Overview
17.1.2 Region Information
17.1.3 Market Information
17.1.4 Background Information
17.1.5 Government Initiatives
17.1.6 Regulations
17.1.7 Regulatory Bodies
17.1.8 Major Associations
17.1.9 Taxes Levied
17.1.10 Corporate Tax Structure
17.1.11 Investments
17.1.12 Major Companies
17.2 Middle East Advanced Drug Delivery Systems Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
17.3 Middle East Advanced Drug Delivery Systems Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
17.4 Middle East Advanced Drug Delivery Systems Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
18 Africa Market
18.1 Summary
18.1.1 Market Overview
18.1.2 Region Information
18.1.3 Market Information
18.1.4 Background Information
18.1.5 Government Initiatives
18.1.6 Regulations
18.1.7 Regulatory Bodies
18.1.8 Major Associations
18.1.9 Taxes Levied
18.1.10 Corporate Tax Structure
18.1.11 Investments
18.1.12 Major Companies
18.2 Africa Advanced Drug Delivery Systems Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
18.3 Africa Advanced Drug Delivery Systems Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
18.4 Africa Advanced Drug Delivery Systems Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
19 Competitive Landscape and Company Profiles
19.1 Company Profile
19.2 Johnson & Johnson
19.2.1 Company Overview
19.2.2 Products And Services
19.2.3 Business Strategy
19.2.4 Financial overview
19.3 Baxter
19.3.1 Company Overview
19.3.2 Products And Services
19.3.3 Business Strategy
19.3.4 Financial Overview
19.4 Becton, Dickinson and Company
19.4.1 Company Overview
19.4.2 Products And Services
19.4.3 Business Strategy
19.4.4 Financial Overview
19.5 Medtronic Plc
19.5.1 Company Overview
19.5.2 Products And Services
19.5.3 Business Strategy
19.5.4 Financial Overview
19.6 Pacira BioSciences, Inc.
19.6.1 Company Overview
19.6.2 Products And Services
19.6.3 Financial Overview
20 Advanced Drug Delivery Systems Market Other Major And Innovative Companies
20.1 Abbvie, Inc.
20.1.1 Company Overview
20.1.2 Products And Services
20.1.3 Business Strategy
20.2 Gilead Sciences, Inc.
20.2.1 Company Overview
20.2.2 Products And Services
20.2.3 Business Strategy
20.3 Merck KGaA
20.3.1 Company Overview
20.3.2 Products And Services
20.3.3 Business Strategy
20.4 Danaher Corporation
20.4.1 Company Overview
20.4.2 Products And Services
20.5 Bausch Health Companies Inc
20.5.1 Company Overview
20.5.2 Products And Services
20.5.3 Business Strategy
20.6 Evonik Industries AG
20.6.1 Company Overview
20.6.2 Products And Services
20.6.3 Business Strategy
20.7 Ypsomed Holding AG
20.7.1 Company Overview
20.7.2 Products And Services
20.7.3 Business Strategy
20.8 SHL Medical AG
20.8.1 Company Overview
20.8.2 Products And Services
20.8.3 Business Strategy
20.9 West Pharmaceutical Services, Inc
20.9.1 Company Overview
20.9.2 Products And Services
20.9.3 Business Strategy
20.10 Novo Nordisk A/S
20.10.1 Company Overview
20.10.2 Products And Services
20.10.3 Business Strategy
20.11 Purdue Pharma LP
20.11.1 Company Overview
20.11.2 Products And Services
20.12 Luye Pharma Group Ltd.
20.12.1 Company Overview
20.12.2 Products And Services
20.13 Ipsen Biopharmaceuticals, Inc
20.13.1 Company Overview
20.13.2 Products And Services
20.13.3 Business Strategy
20.14 Sun Pharmaceutical Inc
20.14.1 Company Overview
20.14.2 Products And Services
20.14.3 Business Strategy
20.15 Takeda Pharmaceutical Company Limited
20.15.1 Company Overview
20.15.2 Products And Services
21 Competitive Benchmarking
22 Competitive Dashboard
23 Key Mergers And Acquisitions
23.1 Cordis Corporation Acquired MedAlliance SA
23.2 DifGen Pharmaceuticals Acquired Aveva Drug Delivery Services Inc
23.3 LTS Lohmann Therapie-Systeme Acquired Sorrel Wearable Injection Device Business From Eitan Medical
